Title : Clinical and economical consequences of the combination of metformin with dipeptidyl peptidase inhibitors in type 2 diabetes patients.

Pub. Date : 2013 Nov

PMID : 23870706






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have analyzed the clinical (diabetic treatment adherence, metabolic control, hypoglycemia and macrovascular complications) and economic (resource use and costs) consequences of the combination of metformin with dipeptidyl peptidase inhibitors (DPPIV) in patients with type 2 diabetes. Metformin dipeptidyl peptidase 4 Homo sapiens
2 Two groups of patients were established: a) metformin with DPPIV and metformin with other diabetic drugs. Metformin dipeptidyl peptidase 4 Homo sapiens
3 CONCLUSIONS: Despite the limitations of the study, patients treated with metformin associated to DPPIV were more likely to show increased adherence, metabolic control and lower rates of hypoglycemia than those treated with metformin associated to other antidiabetics. Metformin dipeptidyl peptidase 4 Homo sapiens